Tyrosine phosphatase-like proteins as autoantigens in insulin-dependent diabetes mellitus: The targets for 37/40k antibodies

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 9, Issue 4, 1996, Pages 183-187

  Bonifacio, E ^a   Christie, M R ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoantigens; Autoimmunity; Islet proteins; Tyrosine phosphatases

Indexed keywords

4 AMINOBUTYRIC ACID; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; PROTEIN TYROSINE PHOSPHATASE;

AUTOIMMUNITY; ETIOLOGY; HUMAN; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR CLONING; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029828533     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., DeCamilli P.: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
2. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L.: Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J. Exp. Med 172: 789-794, 1990.
3. Christie M.R., Hollands J.A., Brown T.J., Michelsen B.K., Delovitch T.L.: Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest. 92: 240-248, 1993.
4. Payton M.A., Hawkes C.J., Christie M.R.: Relationship of the 37,000- and 40.000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511, 1995.
5. Bonifacio E , Lampasona V., Genovese S., Ferrari M., Bosi E.: Identification of protein tyrosine phosphatase-like IA-2 (Islet Cell Antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155: 5419-5426, 1995.
6. Passini N., Larigan J.D., Genovese S., Appella E., Sinigaglia F., Rogge L.: The 37/40-kilodalton autoantigen in insulin-dependent diabetes is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA 92: 9412-9416, 1995.
7. Lu J., Li Q., Xie H., Chen Z., Borovitskaya A.E., Maclaren N.K., Notkins A. L., Lan M. S.: Identification of a second transmembrane protein tyrosine phosphatase. IA-2, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc. Natl. Acad. Sci. USA 93: 2307-2312, 1996.
8. Hawkes C.J., Wasmeier C., Christie M.R., Hutton J.C.: Identification of the 37k-antigen in insulin-dependent diabetes as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes (in press).
9. Christie M.R., Tun R.Y.M., Lo S.S.S., Cassidy D., Brown T.J., Hollands J., Shattock M., Bottazzo G.F., Leslie R.D.G.: Antibodies to glutamic acid decarboxylase and tryptic fragments of islet 64kD antigen as distinct markers for the development of insulin-dependent diabetes. Studies with identical twins. Diabetes 41: 782-787, 1992.
10. Christie M.R., Genovese S., Cassidy D., Bosi E., Brown T.J., Lai M., Bonifacio E., Bottazzo G.F.: Antibodies to islet 37k antigen, but not to glutamate decarboxylase. discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43: 1254-1259, 1994.
11. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M.: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes 43: 1304-1310, 1994.
12. Genovese S., Bingley P. J., Bonifacio E., Christie M.R., Shauock M., Bonfanti R., Foxon R., Gale E.A.M., Bottazzo G. F.: Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 344: 756, 1994.
13. Ongagna J.C., Lévy-Marchal C.: Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia 38: 370, 1995.
14. Bonifacio E., Genovese S., Braghi S., Bazzigaluppi E., Lampasona V., Bingley P.J., Rogge L., Pastore M.R., Bognetti E., Bottazzo G.F., Gale E.A.M., Bosi E.: Islet autoantibody markers in insulin dependent diabetes: identification of screening strategies yielding hish sensitivity. Diabetologia 38: 816-822. 1995.
15. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark Å.: A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350, 1994.
16. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., HoierMadsen M., Boel E., Michelsen B.K., Dyrberg T.: Detection of GAD(65) antibodies in diabetes and other autoimmune disease using a simple radioligand assay. Diabetes 43: 459-467, 1994.
17. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S.: Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type 1 diabetes. J. Clin. Endocrinol. Metab. 73: 1197-1201, 1991.
18. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y. L. S., Martin S., Martin A., Powers A. C., Prochazka M., Naggert J., Leiter E. H., Eisenbarth G. S.: Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest 92: 359-371, 1993.
19. Rabin D.U., Pleasic S., Palmer-Crocker R., Shapiro J.: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41: 183-186, 1992.
20. Lampasona V., Ferrari M., Bosi E., Pastore M.R., Bingley P.J., Bonifacio E.: Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J. Autoimmun. 7: 665-674, 1994.
21. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., Gotdstein D.E., Rae P.M.M.: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152: 3183-3188, 1994.
22. Lan M.S., Lu J., Goto Y., Notkins A.L.: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2. from human insulinoma. DNA Cell Biol. 13: 505-514, 1994.
23. Wasmeier C., Hutton J.C.: Molecular cloning of phogrin, a protein tyrosine phosphatase homologue localised to insulin secretory granule membranes. J. Biol. Chem. 271: 18161-18170, 1946.
24. Lampasona V., Bearzatto M., Genovese S., Bosi E., Ferrari M., Bonifacio E.: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J. Immunol. 157: in press 1996.
25. Stone R.L., Dixon J.E.: Protein-tyrosine phosphatases. J. Biol Chem. 269: 31323, 1994.
26. Lu J., Notkins A.L., Lan M.S.: Isolation, sequence and expression of a novel mouse brain cDN A mlA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem. Biophys. Res. Commun. 204: 930-936, 1994.
27. Zhang Z-Y., Wang Y., Dixon I.E.: Dissecting the catalytic mechanism of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 91: 1624-1627, 1994.
28. Solimena M., Dirkx R., Hermel J.-M., Pleasic-Willianis S., Shapiro J.A.. Caron L., Rabin D.U.: ICA512. an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 15: 2102-2114, 1996.
29. Genovese S., Bonfanti R., Bazzigaluppi E., Lampasona V., Benazzi E., Bosi E., Chiumello G., Bonifacio E.: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39: in press 1996.
30. Hagopian W.A., Sanjeevi C.B., Kockum I., Landin Olsson M., Karlsen A.E., Sundkvist G., Dahlquist G., Palmer J., Lernmark Å.: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 95: 1505-1511, 1995.
31. Genovese S., Bonifacio E., McNally J.M., Dean B.M., Wagner R., Bosi E., Gale E.A.M., Bottazzo G.F.: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388, 1992.
32. Atkinson M.A., Kaufman D.L., Newman D., Tobin A.J., Maclaren N.K.: Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91: 350-356, 1993.
33. Marshall M.O., Høyer P.E., Petersen J.S., Hejnaes K.R., Genovese S., Dyrberg T., Bottazzo G.F.:. Contribution of glutamate decarboxylase antibodies to ICA reactivity. J. Autoimmunity 1: 497, 1994.
34. Myers M.A., Rabin D.U., Rowley M.J.: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44: 1290-1295, 1995.
35. Baekkeskov S., Warnock G., Christie M.R., Rajotte R.V., Larsen P.M., Fey S.: Revelation of specificity of 64k autoantibodies in IDDM serum by high resolution 2D-gel electrophoresis. Unambiguous identification of 64k target antigen. Diabetes 38:1133-1141, 1989.
36. Aanstoot H-J., Kang S-M., Kim J., Lindsay L., Roll U., Knip M., Atkinson M., Mose-Larsen P.,Fey S., Ludvigsson J., Landin M., Bruining J., Maclaren N., Åkerblom H.K., Baekkeskov S.: Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in Type 1 diabetes. J. Clin. Invest. 97: 2772-2783, 1996.
37. Seissler J., Morgenthaler N.G., Achenbach P., Lampeter E.F., Glawe D., Mayton M., Christie M., Scherbaum W.A.: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with insulin-dependent diabetes mellitus. Diabetologia 39: in press 1996.
38. Gianani, R., Rabin D.U., Verge C.F., Yu L., Babu S.R., Pietropaolo M., Eisenbanh G.S.: ICA512 autoantibodies radioassay. Diabetes 44: 1340-1344, 1995.